Jianlong Sheng

434 total citations
10 papers, 264 citations indexed

About

Jianlong Sheng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Oncology. According to data from OpenAlex, Jianlong Sheng has authored 10 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Jianlong Sheng's work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Jianlong Sheng is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Jianlong Sheng collaborates with scholars based in China. Jianlong Sheng's co-authors include Fei He, Banglong Xu, Cheng Cheng, Nina Liu, Youmin Wang, Tianrong Pan, Xiaochen Wang, Cai Chen, Yuting Sun and Jian Xu and has published in prestigious journals such as Journal of the American College of Cardiology, Biomedicine & Pharmacotherapy and Evidence-based Complementary and Alternative Medicine.

In The Last Decade

Jianlong Sheng

9 papers receiving 260 citations

Peers

Jianlong Sheng
Marwa Mohamed Atef Egypt
Chun Tang China
Qianwei Cui China
Nan Mao China
Weiyan Lai China
Huiyan Qu China
Ruochi Zhao China
Regiane Stafim da Cunha Brazil
Trinidad Parra Spain
Marwa Mohamed Atef Egypt
Jianlong Sheng
Citations per year, relative to Jianlong Sheng Jianlong Sheng (= 1×) peers Marwa Mohamed Atef

Countries citing papers authored by Jianlong Sheng

Since Specialization
Citations

This map shows the geographic impact of Jianlong Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianlong Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianlong Sheng more than expected).

Fields of papers citing papers by Jianlong Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianlong Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianlong Sheng. The network helps show where Jianlong Sheng may publish in the future.

Co-authorship network of co-authors of Jianlong Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jianlong Sheng. A scholar is included among the top collaborators of Jianlong Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianlong Sheng. Jianlong Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Xiaohe, et al.. (2024). The Role of Cardiac Macrophages in Inflammation and Fibrosis after Myocardial Ischemia-Reperfusion. Reviews in Cardiovascular Medicine. 25(11). 419–419. 3 indexed citations
2.
Chen, Jiyan, Liwen Li, Xiaojian Gao, et al.. (2024). PCSK9 MONOCLONAL ANTIBODY RECATICIMAB IN ADULT HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (REMAIN-3): A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY. Journal of the American College of Cardiology. 83(13). 1707–1707. 4 indexed citations
3.
Cheng, Cheng, Banglong Xu, Jianlong Sheng, et al.. (2022). Procedural Efficiency, Efficacy, and Safety of High-Power, Short-Duration Radiofrequency Ablation Delivered by STSF Catheter for Paroxysmal Atrial Fibrillation. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 3 indexed citations
4.
5.
He, Fei, et al.. (2020). Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway. Biomedicine & Pharmacotherapy. 133. 110990–110990. 150 indexed citations
6.
7.
Sheng, Jianlong & Jian Xu. (2019). Association of coronary artery disease with toll-likereceptor 4 genetic variants: A meta-analysis. Advances in Clinical and Experimental Medicine. 28(5). 651–658. 2 indexed citations
8.
9.
Liu, Nina, Jianlong Sheng, Tianrong Pan, & Youmin Wang. (2019). Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Lower Extremity Vascular Lesions in Chinese Patients with Type 2 Diabetes. Clinical Laboratory. 65(03/2019). 25 indexed citations
10.
He, Fei, et al.. (2016). Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway. Acta Pharmacologica Sinica. 37(6). 763–771. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marwa Mohamed Atef Breakdown of academic impact, for papers by Chun Tang Breakdown of academic impact, for papers by Qianwei Cui Breakdown of academic impact, for papers by Nan Mao Breakdown of academic impact, for papers by Weiyan Lai Breakdown of academic impact, for papers by Huiyan Qu Breakdown of academic impact, for papers by Ruochi Zhao Breakdown of academic impact, for papers by Regiane Stafim da Cunha Breakdown of academic impact, for papers by Trinidad Parra
Rankless by CCL
2026